Zepzelca (lurbinectedin)

General Description:

Zepzelca (lurbinectedin) is a prescription medication used to treat adult patients with metastatic small cell lung cancer (SCLC) whose disease has progressed following treatment with platinum-based chemotherapy.

GettingZepzelca (lurbinectedin)in India

Zepzelca (lurbinectedin) has been approved in countries like the U.S. and Europe but is not yet available for commercial sale in India. However, it is accessible through the Named Patient Program (NPP) for eligible patients.

MitoGENE helps Indian patients access Zepzelca (lurbinectedin)legally and safely under their doctor’s supervision. We handle the documentation, regulatory approvals, and logistics to ensure compliance with Indian regulations.

If you or your loved one may benefit from Zepzelca (lurbinectedin), MitoGENE is here to support your journey to access this treatment.

Disease Indications:Lung Cancer

Manufacturer:Jazz Pharmaceuticals

Usage:Intravenous

Medicine Approved by:

• Food and Drug Administration (FDA)

Available Dosage Form& Package

• Single-dose vial x 4 mg (lyophilized powder)

Shipping:Cold Chain Shipping. Certain medicines can be affected by heat, light, or improper handling. Cold chain shipping uses temperature-controlled packaging and transport provided by specialized medical couriers to keep these medicines stable and effective. Due to the added care and equipment involved, this method is often more expensive than standard shipping.